Melbourne researchers are calling on healthy people aged 18-70 living in Victoria to roll up their sleeves for a Phase 1...
Australians with cystic fibrosis will soon have access to a new treatment following the listing of Trikafta® on the ...
The Australian government is investing more than $100 million for seasonal influenza vaccines to protect Aus...
Australia's Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company developing next-generation products to...
An in-principle agreement was first announced in December last year for a factory to produce 25 million doses a year fro...
CTT Pharmaceutical Holdings has expanded its reach into additional international markets with a successful patent applic...
Servatus Ltd, an Australian biopharmaceutical company delivering leading novel autoimmune and microbiome therapies, has ...
Telix Pharmaceuticals announces it has made significant progress in advancing the Company's glioblastoma multiforme (GBM...
Through its 10-year Medical Research Future Fund (MRFF) plan, the Australian government is helping Australians live long...
ResApp Health announced positive results for a new novel cough audio-based COVID-19 screening test that only requires a ...
More than $43 million will be invested into mental health and suicide prevention support and services across the Norther...
A novel new therapy has been found to reduce harmful plaque in arteries and change its composition so it is less likely ...
Australia-based Aspen Pharmacare has announced the Therapeutic Goods Administration (TGA) listing of a new medicati...
Australians with lung conditions will be able to access the world’s first and only dedicated lung scanner, which w...
Sentinel lymph node biopsy (SLNB), a procedure used in people diagnosed with melanoma to identify disease spread, has no...
In one of the world’s first plastics contamination-controlled laboratories, Australia-based University of Que...
Australians with blood cancer will receive improved treatment and care through new and continued funding from the Morris...
Eucure Biopharma, a wholly owned subsidiary of Biocytogen, announced the first patient dosing for a phase I multi-r...
